(Q36835244)

16 August 2017

1 reference

title

The case for maternal vaccination against pertussis (English)

1 reference

16 August 2017

0 references

1

Frits R Mooi

1 reference

16 August 2017

Sabine C de Greeff

2

1 reference

16 August 2017

1 September 2007

1 reference

Lancet Infectious Diseases

16 August 2017

1 reference

16 August 2017

7

1 reference

16 August 2017

9

1 reference

16 August 2017

614-624

1 reference

Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Resurgence of pertussis in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Pertussis resurgence in Canada largely caused by a cohort effect.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Temporal trends in circulating Bordetella pertussis strains in Australia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Health burden of pertussis in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Trends in pertussis among infants in the United States, 1980-1999.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Epidemiology of pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Epidemiology and surveillance of pertussis among infants in Catalonia, Spain, during 1997-2001.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Serious pertussis overlooked in infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Early infantile pertussis; increasingly prevalent and potentially fatal

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Pertussis is increasing in unimmunized infants: is a change in policy needed?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Underreporting of pertussis deaths in the United States: need for improved surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Deaths from pertussis are underestimated in England

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Severe and unrecognised: pertussis in UK infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

A comparison of pertussis rates in the Northwest Territories: Pre- and postacellular pertussis vaccine introduction in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Lessons from surveillance; solving the pertussis puzzle

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Effect of the preschool pertussis booster on national notifications of disease in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Maternal antibodies, childhood infections, and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Prospects for prevention of childhood infections by maternal immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Maternal immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Placental transport of immunoglobulin G.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Evolution of maternofetal transport of immunoglobulins during human pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Immunoglobulin A-mediated protection against Bordetella pertussis infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

The most elegant immunological experiment of the XIX century

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

1 reference

7 January 2021

Half-life of the maternal IgG1 allotype in infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Pertussis: an important target for maternal immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Natural history of pertussis antibody in the infant and effect on vaccine response

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Use of erythromycin to prevent pertussis in newborns of mothers with pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Pertussis serostatus among neonates born to Hispanic women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Studies on pertussis immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

A search for serologic correlates of immunity to Bordetella pertussis cough illnesses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Household contact study of Bordetella pertussis infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Serological correlates in whooping cough

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Experimental Whooping Cough

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Serum antibody response to B. pertussis Tn5 mutants, purified PT and FHA in two different mouse strains and passive protection in the murine intranasal infection model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Targeting to Fcgamma receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

THE CLINICAL USES OF HUMAN SERUMS PRESERVED BY THE LYOPHILE PROCESS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Hyperimmune serums in treatment of whooping cough; clinical results, with notes on bacteriologic studies and cutaneous tests

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Failure of hyperimmune gamma globulin to prevent whooping cough

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Antimicrobial treatment of pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Treatment of pertussis with pertussis immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Specific immunoglobulin for treatment of whooping cough

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Treatment of severe pertussis: a study of the safety and pharmacology of intravenous pertussis immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Is pertussis immune globulin efficacious for the treatment of hospitalized infants with pertussis? No answer yet

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Transplacental and Transcolostral Immunity to Pertussis in a Mouse Model Using Acellular Pertussis Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Maternal immunity provides protection against pertussis in newborn piglets

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Endoscopic and transcutaneous ultrasonographic findings and grey-scale histogram analysis in dogs with caerulein-induced pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

AN ATTEMPT TO INCREASE RESISTANCE TO PERTUSSIS IN NEWBORN INFANTS BY IMMUNIZING THEIR MOTHERS DURING PREGNANCY.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

The effects of active immunization of the mother upon the offspring

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Vaccines in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Maternal immunization with Haemophilus influenzae type b vaccines in different populations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Maternal immunization with pneumococcal polysaccharide vaccine in the Philippines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Maternal immunization against viral disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Pertussis of adults and infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Recommendation for an adolescent dose of tetanus and diphtheria toxoids and acellular pertussis vaccine: reassurance for the future

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Reduced-antigen combined diphtheria-tetanus-acellular pertussis vaccine (Boostrix).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

Maternal immunisation in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970113-5

7 January 2021

10.1016/S1473-3099(07)70113-5

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17537674